Chemical formula: C₃₃H₃₅F₄N₃O₂  Molecular mass: 581.656 g/mol  PubChem compound: 49841217

Therapeutic indications

Avacopan is indicated for:

Granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA)

Population group: only adults (18 years old or older)

Avacopan, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.